Grant: Planning and Dissemination Grant - Institute Community Support
Université de Sherbrooke
$20,000.00
Advancing Consent Methods for Transplant Research
EF 2024-25
Résumé
End-stage organ failure is complex and challenging for the Canadian health care system. Patients with end-stage organ failure often require a transplant to save their lives. But there is a growing gap between the number of donors and the number of patients in need of transplantation. Emerging research shows that one way to improve the rate and success of organ transplants is to improve the way organ donors are cared for, immediately prior to donating their organs. Research studies that apply a treatment to organ donors, and measure transplant success in the organ recipients are needed. However, this type of research has many complexities and progress is slow.
The first multicentre study of this kind in Canada, the CINERGY Pilot Trial in Québec, tested the treatment of organ donors with tacrolimus before the organ is donated. The aim is to improve early transplant function, and also transplant longevity. The study identified various obstacles to obtaining a reliable research consent from transplant recipients in the time-constrained context of organ donation and transplantation.
Before embarking on this trial on a national scale, we propose to convene a meeting of all relevant stakeholders to determine the best methods for addressing research consent from the transplant recipients. Stakeholders include transplant and donation physicians and researchers, and the provincial organ donation organizations that organize transplants. Importantly, we will include people whose lives are most affected: someone awaiting transplantation, a prior transplant recipient, and a family member of a prior deceased organ donor. We will also include experts in research ethics and law.
We propose a 2 day meeting of experts to review the CINERGY findings and challenges and develop a framework for the ethical, legal and practical enrolment of recipients in all future studies of this nature. We aim to publish a consensus guidance document in a transplant medical journal.
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
518191
Name
D'Aragon Frederick
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Planning and Dissemination Grants
Projecttitle
Advancing Consent Methods for Transplant Research
Programtype2
Miscellaneous Programs
Orgnameinp2
Université de Sherbrooke
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Knowledge Dissemination; Randomized Controlled Trial; Transplantation
Abstract
End-stage organ failure is complex and challenging for the Canadian health care system. Patients with end-stage organ failure often require a transplant to save their lives. But there is a growing gap between the number of donors and the number of patients in need of transplantation. Emerging research shows that one way to improve the rate and success of organ transplants is to improve the way organ donors are cared for, immediately prior to donating their organs. Research studies that apply a treatment to organ donors, and measure transplant success in the organ recipients are needed. However, this type of research has many complexities and progress is slow.
The first multicentre study of this kind in Canada, the CINERGY Pilot Trial in Québec, tested the treatment of organ donors with tacrolimus before the organ is donated. The aim is to improve early transplant function, and also transplant longevity. The study identified various obstacles to obtaining a reliable research consent from transplant recipients in the time-constrained context of organ donation and transplantation.
Before embarking on this trial on a national scale, we propose to convene a meeting of all relevant stakeholders to determine the best methods for addressing research consent from the transplant recipients. Stakeholders include transplant and donation physicians and researchers, and the provincial organ donation organizations that organize transplants. Importantly, we will include people whose lives are most affected: someone awaiting transplantation, a prior transplant recipient, and a family member of a prior deceased organ donor. We will also include experts in research ethics and law.
We propose a 2 day meeting of experts to review the CINERGY findings and challenges and develop a framework for the ethical, legal and practical enrolment of recipients in all future studies of this nature. We aim to publish a consensus guidance document in a transplant medical journal.
Competitiondate
202411
Approvedterm2
1 yr 0 mth
Pinamesdelim
D'Aragon, Frederick
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $20,000~ $0~